RecruitingNCT01280825
The 1200 Patients Project: Studying the Implementation of Clinical Pharmacogenomic Testing
Sponsor
University of Chicago
Enrollment
1,200 participants
Start Date
Jan 14, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this study is to collect DNA samples from patients undergoing routine care at the University of Chicago. These samples will be tested for differences in genes that may suggest greater risk of side effects or chance of increased benefit from certain medications. The results will be made available to the patient's treating physician and the researchers will track whether or not this information is used in routine health care.
Eligibility
Min Age: 18 Years
Inclusion Criteria11
- Receiving ongoing, out-patient care at the University of Chicago Medical Center under the routine care of a physician participating in this trial
- Life expectancy of at least 3 years
- Must be 18 years or older
- Must be taking at least 1 (but not more than 6) prescription medications at the time of enrollment OR be 65 years or older OR be reasonably expected to require the use of a prescription medication within the next 5 years
- Patients with certain diseases, or likely to receive or be receiving certain drugs, will be targeted particularly for enrollment in order to enrich the study for patients likely to have pharmacogenetically relevant interactions, including, but not limited to:
- Patients requiring specialized cardiology care
- Patients with inflammatory bowel diseases
- Patients with systemic autoimmune or inflammatory diseases
- Patients requiring long-term oral anticoagulation
- Patients with hepatitis C
- Patients with non-metastatic cancer
Exclusion Criteria3
- Patients with acute or chronic disease which could be reasonably expected to result in the patient's death within the next 3 years.
- Patients who have undergone, or are being actively considered for, liver or kidney transplantation.
- Inability to understand and give informed consent to participate.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01280825
Related Trials
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer
NCT0381634552 locations
Archival of Human Biological Samples in CU-Med Biobank
NCT047064811 location
Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
NCT0631003132 locations
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395126 locations
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
NCT06226883159 locations